BCWM
WST icon

Bartlett & Co Wealth Management’s West Pharmaceutical WST Stock Holding History

Bartlett & Co Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.38K Buy
15
+1
+7% +$306 ﹤0.01% 1080
2026
Q1 		$4.21K Buy
14
+2
+17% +$498 ﹤0.01% 1039
2025
Q4 		$3.3K Hold
12
– – ﹤0.01% 1071
2025
Q3 		$3.15K Buy
12
+11
+1,100% +$2.67K ﹤0.01% 1056
2025
Q2 		$219 Buy
+1
New +$214 ﹤0.01% 1197
2024
Q2 		– Sell
-1
Closed -$396 – 1174
2024
Q1 		$396 Buy
+1
New +$370 ﹤0.01% 1092
2022
Q4 		– Sell
-7
Closed -$1.72K – 1195
2022
Q3 		$1.72K Sell
7
-9
-56% -$2.74K ﹤0.01% 1063
2022
Q2 		$4.84K Buy
+16
New +$5.21K ﹤0.01% 1022

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bartlett & Co Wealth Management's WST Position: Q2 2026 in Review

Bartlett & Co Wealth Management increased its West Pharmaceutical (WST) stake by 7.1% in Q2 2026, buying an estimated $306 and bringing the position to 15 shares worth $5.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

Bartlett & Co Wealth Management first reported a position in WST in Q2 2022 and has held it in 8 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Bartlett & Co Wealth Management held 15 shares of West Pharmaceutical worth $5.38K as of Q2 2026.
  • Bartlett & Co Wealth Management bought 1 West Pharmaceutical share in Q2 2026, an estimated $306.
  • West Pharmaceutical made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #1080 holding.
  • Bartlett & Co Wealth Management first reported a position in West Pharmaceutical in Q2 2022 and has held it in 8 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.